PT1622629E - Composição de libertação controlada contendo um sal de estrôncio - Google Patents

Composição de libertação controlada contendo um sal de estrôncio Download PDF

Info

Publication number
PT1622629E
PT1622629E PT47313077T PT04731307T PT1622629E PT 1622629 E PT1622629 E PT 1622629E PT 47313077 T PT47313077 T PT 47313077T PT 04731307 T PT04731307 T PT 04731307T PT 1622629 E PT1622629 E PT 1622629E
Authority
PT
Portugal
Prior art keywords
strontium
acid
bone
use according
osteoporosis
Prior art date
Application number
PT47313077T
Other languages
English (en)
Portuguese (pt)
Inventor
Stephan Christgau
Christian Hansen
Jens E T Andersen
Henrik Nilsson
Original Assignee
Osteologix As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Osteologix As filed Critical Osteologix As
Publication of PT1622629E publication Critical patent/PT1622629E/pt

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PT47313077T 2003-05-07 2004-05-06 Composição de libertação controlada contendo um sal de estrôncio PT1622629E (pt)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DKPA200300691 2003-05-07
DKPA200301043 2003-07-08
US52840903P 2003-12-09 2003-12-09
DKPA200301821 2003-12-09

Publications (1)

Publication Number Publication Date
PT1622629E true PT1622629E (pt) 2013-09-05

Family

ID=49289803

Family Applications (1)

Application Number Title Priority Date Filing Date
PT47313077T PT1622629E (pt) 2003-05-07 2004-05-06 Composição de libertação controlada contendo um sal de estrôncio

Country Status (4)

Country Link
DK (1) DK1622629T3 (es)
ES (1) ES2431890T3 (es)
PT (1) PT1622629E (es)
SI (1) SI1622629T1 (es)

Also Published As

Publication number Publication date
DK1622629T3 (da) 2013-10-07
ES2431890T3 (es) 2013-11-28
SI1622629T1 (sl) 2013-10-30

Similar Documents

Publication Publication Date Title
AU2010249227B2 (en) Controlled release composition containing a strontium salt
ES2275218T3 (es) Sales de estroncio hidrosolubles para el tratamiento de afecciones de cartilagos y/o huesos.
EP1622630B1 (en) Strontium combinations for the prophylaxis/treatment of cartilage and/or bone conditions
US8324191B2 (en) Combined calcium, magnesium and vitamin D supplements
JP2002529407A (ja) Ｌ−ｄｏｐａエチルエステル含有分散性組成物
AU625809B2 (en) Novel calcium supplements
PT1446112E (pt) Utilização de glutamato, derivados ou metabolitos de glutamato, análogos de glutamato ou misturas dos mesmos para o fabrico de uma composição para o tratamento da osteoporose
CN101175477A (zh) 碘塞罗宁的控释药物组合物及其制备和使用方法
US5294634A (en) Osteogenesis promoter
PT96447B (pt) Processo para a preparacao de um hemi-hidrato de um derivado de tetra-hidroimidazo-piridina
ES2431890T3 (es) Composición de liberación controlada que contiene una sal de estroncio
ES2423517T3 (es) Sales de estroncio solubles en agua para su uso en el tratamiento de afecciones del cartílago y/o de los huesos
AU2022232924A1 (en) Endoxifen for treatment of ovarian cancer
JPWO2004002499A1 (ja) 便秘及び便秘に伴う症状の予防及び／又は治療のための医薬
JPH09157174A (ja) カルシウム製剤
JP2020527168A (ja) アザピロン系化合物の副交感神経の機能向上の使用
JP2005139463A (ja) ポリカルボフィルマグネシウムの製造方法